Cargando…
COVID-19 in neuromyelitis optica spectrum disorder patients in Poland
Autores principales: | Podlecka-Piętowska, Aleksandra, Barć, Krzysztof, Denisiuk, Agata, Nojszewska, Monika, Zakrzewska-Pniewska, Beata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858004/ https://www.ncbi.nlm.nih.gov/pubmed/35228113 http://dx.doi.org/10.1016/j.msard.2022.103698 |
Ejemplares similares
-
Altered Cerebrospinal Fluid Concentrations of Hydrophobic and Hydrophilic Compounds in Early Stages of Multiple Sclerosis—Metabolic Profile Analyses
por: Podlecka-Piętowska, A., et al.
Publicado: (2019) -
Search for viral agents in cerebrospinal fluid in patients with multiple sclerosis using real-time PCR and metagenomics
por: Perlejewski, Karol, et al.
Publicado: (2020) -
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
por: Ramanathan, Ramnath Santosh, et al.
Publicado: (2014) -
Neuromyelitis Optica Spectrum Disorder
por: Cazzaniga, Juliana, et al.
Publicado: (2023) -
Sexual dysfunction in female patients with relapsing‐remitting multiple sclerosis
por: Bartnik, Pawel, et al.
Publicado: (2017)